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Abstract: In this study, a series of twenty-two ring-substituted naphthalene-1-
carboxanilides were prepared and characterized. Primary in vitro screening of the 
synthesized carboxanilides was performed against Mycobacterium avium subsp. 
paratuberculosis. N-(2-Methoxyphenyl)naphthalene-1-carboxamide, N-(3-methoxy-
phenyl)naphthalene-1-carboxamide, N-(3-methylphenyl)naphthalene-1-carboxamide,  
N-(4-methylphenyl)naphthalene-1-carboxamide and N-(3-fluorophenyl)naphthalene-1-
carboxamide showed against M. avium subsp. paratuberculosis two-fold higher activity 
than rifampicin and three-fold higher activity than ciprofloxacin. The most effective 
antimycobacterial compounds demonstrated insignificant toxicity against the human 
monocytic leukemia THP-1 cell line. The testing of biological activity of the compounds 
was completed with the study of photosynthetic electron transport (PET) inhibition in 
isolated spinach (Spinacia oleracea L.) chloroplasts. The PET-inhibiting activity expressed 
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by IC50 value of the most active compound N-[4-(trifluoromethyl)phenyl]naphthalene-1-
carboxamide was 59 μmol/L. The structure-activity relationships are discussed. 
Keywords: naphthalene; lipophilicity; in vitro antimycobacterial activity; in vitro 
cytotoxicity; photosynthetic electron transport inhibition; spinach chloroplasts 
 
1. Introduction 
Mycobacterium tuberculosis is the pathogen responsible for tuberculosis (TB). This disorder is more 
prevalent in the world today than at any other time. The number of notified cases of multi-drug-resistant 
strains of M. tuberculosis (MDR-TB) is increasing in 27 high MDR-TB burden countries. In addition, 
other non-tuberculous mycobacteria (NTM) are now recognized as significant human pathogens and 
cause difficult-to-treat or incurable diseases, such as pulmonary disease, lymphadenitis, skin and soft 
tissue disease, gastrointestinal and skeletal infections, and potentially resulting in death, especially in 
cases involving immunocompromised patients. The emergence of NTM underlines the urgency of 
searching for new structure types of drugs; it also seems to be important to re-engineer and re-test old 
drug families to achieve effective control of both TB and NTM [1–3]. 
As biologically active compounds, including drugs and pesticides, target particular biological 
systems, some herbicides can also have molecular sites of action in mammals/non-plant organisms. 
However, targeting compounds to biological systems with similar physicochemical properties can lead to 
completely different biological responses in plants and animals. Therefore, many innovative/original 
pharmaceutical companies perform screening of biologically active compounds, not only as potential 
drugs, but also as potential pesticides. For example, fluconazole was firstly discovered as a potent 
pesticide, and subsequently it was confirmed as an antifungal drug [4–6]. Moreover, good correlation 
between microbiological activities and herbicidal or antialgal effects was found [7–18]. 
The presence of an amide (-NHCO-) group [19,20] is characteristic of a number of biologically 
active compounds, such as antimicrobials, antiprotozoals, antineoplastics, antivirotics, 
anti-inflammatory agents or herbicides [7,9,12,13,21–28]. The wide spectrum of biological effects of 
substituted (mono/diaza)naphthalene scaffolds includes especially anti-infective and antineoplastics 
activity [9–12,21,29–42]. In addition, some (aza)naphthalene derivatives also showed noteworthy 
herbicidal activity [9–13,24,30,32,34] explained by reversible binding to photosystem II (PS II), 
a membrane-protein complex in the thylakoid membranes, which catalyses the oxidation of water and 
the reduction of plastoquinone [43], and, thereby, inhibit photosynthesis [44–46]. 
In the context of the previously-described azanaphtalenes [24,30–37] or various amides [8–12,25–28], 
ring-substituted naphthalene-1-carboxanilides as biologically active compounds were investigated. All 
the compounds were tested for activity against NTM species—M. avium subsp. paratuberculosis and 
additionally they were assessed for their potency to inhibit photosynthetic electron transport in isolated 
spinach chloroplasts (Spinacia oleracea L.). Relationships between the structure and their in vitro 
antimycobacterial activity or/and activity related to inhibition of photosynthetic electron transport 
(PET) in isolated spinach chloroplasts are discussed. 
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2. Results and Discussion 
2.1. Chemistry 
The studied compounds were prepared using two methods according to Scheme 1. The discussed 
compounds were synthesized by using two-step synthesis (Method A: a,b) via 1-naphthoyl chloride as 
intermediate [9] or by one-pot microwave-assisted synthesis (Method B: c) [10]. Both methods yielded 
a series of twenty-two N-substituted naphthalene-1-carboxanilides 1–8c. 
Scheme 1. Synthesis of ring-substituted naphthalene-1-carboxanilides 1–8c. 
 
Reagents and conditions: (a) SOCl2, toluene; (b) triethylamine, dichloromethane, (substitute) aniline;  
(c) PCl3, chlorobenzene, (substitute) aniline, MW. 
2.2. Lipophilicity Characteristics and Electronic Properties 
Within structure-activity relationship investigations of various molecular descriptors, topological 
indexes or parameters describing physicochemical properties are used. Thus, they represent numerical 
values that characterize properties of molecules that influence biological activity (receptor binding). In 
our previous studies biological activity was strongly influenced especially by lipophilicity and 
electronic parameters [7–13,24–28,30–37], expressed either as Hammett’s σ parameters or Taft polar 
substituent constants σ*. 
Lipophilicity is a property that has a major effect on bioavailability, biotransformation as well as 
pharmacological activity, because drugs cross biological membranes through passive transport, which 
strongly depends on their lipophilicity. Lipophilicity of the studied compounds was determined by 
RP-HPLC as capacity factor logarithm (log k). The procedure was performed under isocratic 
conditions with methanol as an organic modifier in the mobile phase using an end-capped non-polar 
C18 stationary RP column. The results of ring-substituted naphthalene-1-carboxanilides 1–8c are shown in 
Table 1 and illustrated in Figure 1. The highest experimental lipophilicity was found for N-[4-
(trifluoromethyl)-phenyl]naphthalene-1-carboxamide (7c), while N-(4-methoxyphenyl)naphthalene-1-
carboxamide (2c) showed the lowest log k value. Lipophilicity was also calculated as log P using 
ACD/Percepta ver. 2012 (Advanced Chemistry Development, Inc., Toronto, ON, Canada). 
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Table 1. Structure of ring-substituted naphthalene-1-carboxanilides 1–8c, experimentally 
determined values of lipophilicity log k, calculated values of lipophilicity (log P), predicted 
hydrophobic distributive parameter π, predicted polar substituent constants σ*, in vitro 
antimycobacterial activity (MIC/IC90) of compounds against clinical isolate of 
Mycobacterium avium subsp. paratuberculosis CIT03 (MAP) in comparison with isoniazid 
(INH), ciprofloxacin (CPX), and rifampicin (RIF) standards, in vitro cytotoxicity assay 
(LD50) of choice compounds and IC50 values related to PET inhibition in isolated spinach 
chloroplasts in comparison with 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU) standard. 
Comp. R1 log k log P a π a σ* a MAP MIC/IC90
[μmol/L] 
LD50 
[μmol/L] 
PET 
IC50 [μmol/L] 
1 H 0.5620 3.88 0.40 0.26 b − c 
2a 2-OCH3 0.8013 3.60 0.30 0.29 54 >30 c 
2b 3-OCH3 0.6087 3.76 0.56 0.30 54 >30 c 
2c 4-OCH3 0.4953 3.76 0.35 0.38 b − c 
3a 2-CH3 0.5309 4.42 0.86 0.29 b − c 
3b 3-CH3 0.7624 4.42 0.86 0.30 57 >30 136 
3c 4-CH3 0.7551 4.42 0.86 0.38 57 >30 381 
4a 2-F 0.5592 3.78 0.36 0.31 b − c 
4b 3-F 0.7204 4.05 0.89 0.32 57 >30 131 
4c 4-F 0.6315 3.67 0.85 0.39 b − c 
5a 2-Cl 0.8322 4.48 0.91 0.33 b − c 
5b 3-Cl 0.9357 4.75 1.54 0.32 b − 107 
5c 4-Cl 0.9223 4.60 1.19 0.40 b − 102 
6a 2-Br 0.8892 4.68 1.08 0.31 b − c 
6b 3-Br 1.0047 4.92 1.61 0.31 b − 278 
6c 4-Br 0.9985 4.76 1.57 0.40 184 − 365 
7a 2-CF3 0.7595 4.64 1.59 0.27 b − c 
7b 3-CF3 1.0862 5.22 1.75 0.33 b − 114 
7c 4-CF3 1.1480 4.68 1.41 0.41 793 − 59 
8a 2-NO2 0.9090 3.98 0.65 0.27 b − 476 
8b 3-NO2 0.8155 4.00 0.79 0.34 b − 492 
8c 4-NO2 0.7328 3.67 0.49 0.43 b − 129 
DCMU – – − − − − − 1.9 
INH − − − − − 1823 − − 
CPX − − − − − 181 − − 
RIF − − − − − 109 − − 
a calculated using ACD/Percepta (Advanced Chemistry Development, Inc., Toronto, ON, Canada, 2012):  
π: hydrophobicity contribution of the substituent in position 1 of naphthalene core, σ *: electron properties 
contribution of the substituent in position 1 of naphthalene core; b no activity; c precipitation during experiment. 
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Figure 1. Match of experimentally found log k values with calculated log P data of  
ortho-substituted (A) and meta- and para-substituted derivatives (B) and with calculated 
distributive parameter π (hydrophobicity contribution of the substituent in position 1 of 
naphthalene) of ortho-substituted (C) and meta- and para-substituted derivatives (D). 
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The results obtained with all the ring-substituted naphthalene-1-carboxanilides show that the 
experimentally-determined lipophilicity (log k) of the discussed compounds poorly correlates with the 
calculated values log P of compounds 1–8c as shown in Figure 1A,B. For the ortho-substituted 
derivatives no correlation was found. Similar poor correlation between experimentally and predicted 
lipophilicity values was described for ring-substituted 2-hydroxynaphthalene-1-carboxanilides and  
1-hydroxynaphthalene-2-carboxanilides [11,12] and for hydroxyquinolinecarboxamides [24]; 
nevertheless, this poor correlation was attributed to the phenolic moiety in the position vicinal to the 
carboxamide group. As there is no any phenolic moiety in these structures, lipophilicity was 
additionally expressed as a hydrophobic distributive parameter π of the carboxamide moiety and ring-
substituted phenyl; it was also calculated using ACD/Percepta, see Table 1. Again, it can be stated that 
no match of log k to π of the ortho-substituted compounds was found (Figure 1C), while the meta- and 
para-substituted derivatives showed better match, see Figure 1D. The most significant deviations 
within the dependence illustrated in Figure 1D can be observed for 4-CF3 (7c) and 4-NO2 (8c). 
Based on these observations, some intramolecular interactions between the carboxamide moiety and 
the phenyl substituents could be supposed that influence the resulting lipophilicity of compounds. 
These interactions are characterized rather by using distributive parameter π of substituents in position 1 
of naphthalene than by using log P parameter of the whole molecule. Differences between expected 
and found values were also observed during TLC, when the purity of the final compounds was 
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checked. Ab initio/DFT calculations of charges in individual structures could provide more detailed 
information, nevertheless, such investigation was not the aim of this paper. 
The influence of R substituents on lipophilicity (log k) is as follows within ortho-substituted 
derivatives: CH3 < F = H < CF3 < OCH3 < Cl < Br < NO2 and as follows within meta- and  
para-substituted derivatives: OCH3 ≈ H < F < CH3 < NO2 < Cl < Br < CF3. Within the individual 
series the lipophilicity determined by log k values increases for halogens and methyl substituents as 
follows: ortho < para < meta; for OCH3 and NO2 as follows: para < meta < ortho. It can be assumed 
that log k values specify lipophilicity within individual series of the studied compounds. 
Based on the above-mentioned observations, electronic properties of prepared compounds 1–8c 
were expressed as polar substituent constants σ* of the whole substituent in position 1 of naphthalene, 
i.e., influence of carboxamide moiety and ring-substituted phenyl was included. The individual σ* 
parameters were predicted using the ACD/Percepta software; they ranged from 0.26 (1, R = H) to 0.43 
(8c, R = 4-NO2). 
2.3. In Vitro Antimycobacterial Evaluation 
In vitro antimycobacterial screening of all the compounds against Mycobacterium avium subsp. 
paratuberculosis was performed, however most compounds did not show any activity (higher than  
793 μmol/L). Only the eight compounds presented in Table 1 showed antimycobacterial effectivity. 
The antimycobacterial activity was expressed as minimum inhibitory concentration (MIC) that is 
defined for mycobacteria as a 90% or greater (IC90) reduction of growth in comparison with the 
control. The MIC/IC90 value is routinely and widely used in bacterial assays and is a standard detection 
limit according to the Clinical and Laboratory Standards Institute [47]. N-(2-Methoxyphenyl)naphthalene-
1-carboxamide (2a), N-(3-methoxyphenyl)naphthalene-1-carboxamide (2b), N-(3-
methylphenyl)naphthalene-1-carboxamide (3b), N-(4-methylphenyl)-naphthalene-1-carboxamide (3c) 
and N-(3-fluorophenyl)naphthalene-1-carboxamide (4b) demonstrated two-fold higher activity than 
rifampicin and three-fold higher activity than ciprofloxacin. 
Figure 2 shows dependence of the antimycobacterial activities expressed as log(1/MIC [mol/L]) on 
lipophilicity expressed as log k (Figure 2A), distributive parameter π (Figure 2B) and electronic 
properties expressed as polar substituent constants σ* (Figure 2C). When inactive compound 1 (R = H) 
was eliminated (marked by cross), the dependences of log(1/MIC) on log k and of log(1/MIC) on σ* 
were biphasic: in the range of π from 0.6087 (2b) to 0.8013 (2a), as well as in the range of σ* from 
0.29 (2a) to 0.38 (3c) the antimycobacterial activity remained practically constant while a further 
increase of log k or σ* resulted in a strong activity decrease. Consequently, it can be concluded that the 
lipophilicity of compounds higher than log k = 0.8013 is adverse in terms of antimycobacterial activity; 
increased electron-withdrawing properties of the whole substituent in position 1 of naphthalene (expressed 
as polar substituent constants σ*) exceeding value σ* = 0.38 are also unfavourable. 
When antimycobacterial activities of both series of naphthalene-2-carboxanilides [9] and 
naphthalene-1-carboxanilides are compared, it can be stated that the discussed 1-carboxanilides 
demonstrated significantly higher activity. Comparison of 2-hydroxynaphthalene-1-carboxanilides [11] 
with naphthalene-1-carboxanilides is more complicated. It can be stated that 2-hydroxy derivatives 
showed wider spectrum of antimycobacterial effect; nevertheless when MICs of compounds and the 
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standards are compared, it seems that compounds presented herein demonstrated more potent activity. 
In general it can be stated that in both series derivatives with lipophilicity log k > 0.6 can show 
antimycobacterial effect, and within both series rather meta-substituted derivatives demonstrated 
higher activity, which can be connected with the planarity of the structure [9,11,12], nevertheless in 
the series of 2-hydroxynaphthalene-1-carboxanilides substituents with significant electron-withdrawing 
effect are favoured [11], while among naphthalene-1-carboxanilides rather electron-neutral or slightly 
electron-withdrawing substituents are preferable, i.e., phenyl substituents with minimal effect on 
electronic density at the carboxamide moiety [10–12]. 
Figure 2. Dependence of in vitro antimycobacterial activity against Mycobacterium avium 
subsp. paratuberculosis log(1/MIC [mol/L]) on lipophilicity expressed as log k (A) or 
distributive parameter π (B), as well as polar substituent constants σ* (C) of selected 
studied compounds. (π: hydrophobicity contribution of the substituent in position 1 of 
naphthalene, σ*: electron properties contribution of the substituent in position 1 of 
naphthalene; eliminated compound 1 marked by cross) 
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Of the eight compounds the three with the best efficacy were used to monitor their effect on the 
viability of M. avium subsp. paratuberculosis CIT03 over a period of five days, see Figure 3. A 
concentration range starting at 1,000 µg/mL to 15 µg/mL was used for compounds 2b, 3c, and 4b. The 
percent reduction of alamarBlue of these three compounds was compared to an untreated control of  
M. avium subsp. paratuberculosis and the standards rifampicin and ciprofloxacin. Figure 3A illustrates 
the dependence of the percent reduction of alamarBlue of compounds 2b, 3c, and 4b at their MICs  
(15 µg/mL, i.e., 54, 57, and 57 µmol/L) on time in comparison with ciprofloxacin (CPX) and 
rifampicin (RIF) standards at their MICs (60 and 90 µg/mL, i.e., 181 and 109 µmol/L) and the 
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untreated control of M. avium subsp. paratuberculosis. Figure 3B–D show in detail individual 
dependences of the percent reduction of alamarBlue on time (in days) at various concentrations of the 
individual compounds (range from 1000 to 15 µg/mL) in comparison with the standards at their MICs. 
The percent reduction values for all treated M. avium subsp. paratuberculosis samples were less than 
20% over the five-day period of testing. As previously outlined by Carroll et al. [48], percent reduction 
values less than 20% indicate insufficient cell metabolism and hence lack of cell viability. 
Additionally, a standard MTT assay was performed on these same compounds. The MTT assay is a 
well-characterized method of assessing cell growth through measurement of respiration. As such, a 
low level of cell viability may suggest inhibition of cell growth through respiratory inhibition [49].  
3-Methoxy (2b) and 4-methyl (3c) derivatives showed more than 80% reduction in activity at the 
lowest tested concentration (8 µg/mL, i.e., ca. 30 µmol/L) after four hours of incubation, similar to the 
reduction observed in the rifampicin and ciprofloxacin standards. Compounds 2a and 4b achieved 
similar levels of inhibition at 16 µg/mL (ca. 60 µmol/L) concentration. 
Figure 3. Viability of M. avium subsp. paratuberculosis expressed as percent reduction of 
alamarBlue over a period of five days after treatment with selected studied compounds 2b, 
3c, and 4b in comparison with untreated control of M. avium subsp. paratuberculosis and 
standards ciprofloxacin (CPX) and rifampicin (RIF) at their MICs (A). Viability of M. 
avium subsp. paratuberculosis expressed as percent reduction of alamarBlue over a period of 
five days after treatment with selected studied compounds 2b (B), 3c (C), and 4b (D) at 
different concentrations (1,000–15 µg/mL) in comparison with CPX and RIF at their MICs. 
0
10
20
30
40
50
60
70
1 2 3 4 5
al
am
ar
Bl
ue
 re
du
ct
io
n
[%
]
Time [days]
untreated 2b 3c 4b RIF CPX
A
8
10
12
14
16
18
20
1 2 3 4 5
al
am
ar
Bl
ue
 re
du
ct
io
n [
%
]
Time [days]
1000 500 250 125 62
31 15 RIF CPX
B
8
10
12
14
16
18
20
1 2 3 4 5
al
am
ar
Bl
ue
 re
du
ct
io
n [
%
]
Time [days]
1000 500 250 125 62
31 15 RIF CPX
C
8
10
12
14
16
18
20
1 2 3 4 5
al
am
ar
Bl
ue
 re
du
ct
io
n [
%
]
Time [days]
1000 500 250 125 62
31 15 RIF CPX
D
 
Molecules 2014, 19 10394 
 
 
Janin mentioned that a similar type of carboxamides can interfere with the mycobacterial proton 
pump F0F1H+ATPase or inhibit biosynthesis of amino acids [50]. This hypothesis was confirmed in 
recently published papers [3,51,52], where the mechanism of action of bedaquiline (TMC-207, I) and 
its naphthalene analogues (II) as potent compounds inhibiting the respiratory chain of mycobacteria is 
discussed. Based on structure analogy, the discussed ring-substituted naphthalene-1-carboxanilides can 
be considered as simplified derivatives of bedaquiline and its naphthalene analogues, see Figure 4. 
Since the change in colour of alamarBlue is caused by a decrease of mycobacterial cell metabolism, it 
is possible that these compounds bind to the mycobacterial respiratory chain components. However, 
another possible site of action of the studied compounds in the mycobacteria cannot be excluded. 
Figure 4. Structural analogy of the most effective compounds 2a, 2b, 3c, 4b to bedaquiline 
(TMC-207, I) and its naphthalene analogues (II) [3,50]. 
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2.4. In Vitro Cytotoxicity Assay 
The preliminary in vitro screening of cytotoxicity of the most effective antimycobacterial 
compounds 2a, 2b, 3b, 3c, and 4b was performed using the human monocytic leukemia THP-1 cell 
line. The cytotoxicity was evaluated as the LD50 value (LD50-lethal dose to 50% of the cell 
population), see Table 1. The discussed anilides 2a, 2b, 3b, 3c and 4b were not soluble at 
concentrations above 30 μmol/L in testing medium containing 0.1% DMSO, therefore the highest 
available concentration 30.0 μmol/L was used for the toxicity assay. Treatment with 30 μmol/L of 2a, 
2b, 3b, 3c, and 4b did not lead to significant lethal effect on THP-1 cells (e.g., LD50 of oxaliplatin and 
of camptothecin assessed in this line formerly showed similar values: 1.7 ± 0.64 μmol/L and 0.16 ± 
0.07 μmol/L, respectively). Based on these observations it can be concluded that the discussed anilides 
with antimycobacterial efficacy are nontoxic [53] and therefore they can be considered as promising 
agents for subsequent design of novel antimycobacterial agents. 
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2.5. Inhibition of Photosynthetic Electron Transport (PET) in Spinach Chloroplasts 
The evaluated naphthanilide derivatives showed moderate or low inhibition of photosynthetic 
electron transport (PET) in isolated spinach (Spinacia oleracea L.) chloroplasts compared with the 
standard, see Table 1. The PET-inhibiting activity was expressed by IC50 value, i.e., compound 
concentration in mol/L causing 50% inhibition of PET. Generally compounds showed poor aqueous 
solubility and IC50 values of 1–3a, 4a, 4c, 5a, 6a, and 7a could not be determined due to precipitation 
of the compounds during the experiments. From rest twelve compounds compound 7c (R = 4-CF3) 
expressed the highest PET-inhibiting activity (IC50 = 59 µmol/L), while compound 8b (R = 3-NO2) 
expressed the lowest PET-inhibiting activity (IC50 = 492 µmol/L). However, it could be noted that 
limited solubility in tested medium at higher compound concentrations was observed also for 3c, 6b, 
6c, 8a, and 8b. 
Figure 5. Relationships between PET inhibition log(1/IC50) [mol/L] in isolated spinach 
chloroplasts and lipophilicity expressed as log k (A) or distributive parameter π (B), as well 
as polar substituent constants σ* (C) of selected studied compounds. (π: hydrophobicity 
contribution of the substituent in position 1 of naphthalene, σ*: electron properties 
contribution of the substituent in position 1 of naphthalene; eliminated compounds 3c, 6b, 
6c, 8a, 8b marked by crosses) 
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Dependences of log(1/IC50) on the lipophilicity of compounds expressed as log k (Figure 5A) as 
well as distributive parameter π (Figure 5B) and electronic properties expressed as polar substituent 
constants σ* (Figure 2C) are presented in Figure 2. When compounds with reduced solubility in tested 
medium, namely 3c (R = 4-CH3), 6b,c (R = 3-Br, 4-Br), and 8a,b (R = 2-NO2, 3-NO2) were eliminated 
(marked by crosses) the dependence of log(1/IC50 [mol/L]) on log k illustrated for seven compounds 
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(3b, 4b, 5b, 5c, 7b, 7c, 8c) seems to be approximately linear. On the other hand, the dependence of 
PET-inhibiting activity on distributive parameter π of the whole substituents in position 1 of 
naphthalene showed bilinear dependence, the activity increased up to π = 1.41 (R = 4-CF3, compound 7c) 
and further lipophilicity increase resulted in activity decrease. The dependence of PET inhibition on 
the electronic properties σ* of the whole substituents in position 1 of naphthalene, showed also 
biphasic course with the optimum σ* = 0.41 (compound 7c). 
When the PET-inhibiting activity is compared with that of 2-hydroxynaphthalene-1- 
carboxanilides [11], it can be stated that 2-hydroxy derivatives showed higher solubility and higher 
activity, nevertheless similar relationships between PET inhibition and lipophilicity and electronic 
parameters of substituents were observed. Completely different dependences of PET inhibition on 
lipophilicity and electronic parameters of substituents were found within the series of naphthalene-2-
carboxanilides [9]. 
3. Experimental Section 
3.1. General 
All reagents were purchased from Aldrich. TLC experiments were performed on alumina-backed 
silica gel 40 F254 plates (Merck, Darmstadt, Germany) using chloroform/acetone (2:1) as a mobile phase. 
The plates were illuminated under UV (254 nm) and evaluated in iodine vapor. The melting points were 
determined on Kofler hot-plate apparatus HMK (Franz Kustner Nacht KG, Dresden, Germany) and are 
uncorrected. Infrared (IR) spectra were recorded on a Smart MIRacle™ ATR ZnSe for Nicolet™ 
Impact 410 FT-IR spectrometer (Thermo Scientific, West Palm Beach, FL, USA). The spectra were 
obtained by accumulation of 256 scans with 2 cm−1 resolution in the region of 4,000–600 cm−1. All 1H 
and 13C-NMR spectra were recorded on a Bruker Avance III 400 MHz FT-NMR spectrometer  
(400 MHz for 1H and 100 MHz for 13C, Bruker Comp., Karlsruhe, Germany). Chemical shifts are 
reported in ppm () using internal Si(CH3)4 as the reference with diffuse, easily exchangeable signals 
being omitted. Mass spectra were measured using a LTQ Orbitrap Hybrid Mass Spectrometer (Thermo 
Electron Corporation, USA) with direct injection into an APCI source (400 °C) in the positive mode. 
3.2. Synthesis 
General Procedure for Synthesis of Carboxamide Derivatives 1–8c 
Method A: Naphthalene-1-carboxylic acid (5.8 mmol) was dissolved in dry hot toluene (40 mL) and 
thionyl chloride (8.0 mmol) was added. After 2 h of refluxing, solvent and excessive thionyl chloride 
were evaporated under reduced pressure giving napthalene-1-carbonyl chloride as colourless liquid in 
quantitative yield. The product forms colourless needles after cooling. Mp. 18–19 °C (26 °C [54]). 
Naphthalene-1-carbonyl chloride (5.8 mmol), triethylamine (8.7 mmol) and corresponding substituted 
aniline (5.8 mmol) were dissolved in dry dichloromethane (30 mL) and the mixture was stirred for 12 h at 
ambient temperature. The solvent was evaporated under reduced pressure, the solid residue washed 
with 10% HCl, and the crude product was recrystallized from propan-2-ol with addition of active carbon. 
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Method B: Naphthalene-1-carboxylic acid (5.8 mmol) and the corresponding substituted aniline 
(5.8 mmol) were suspended in dry chlorobenzene (25 mL). Phosphorous trichloride (2.9 mmol) was 
added dropwise, and the reacting mixture was heated in the microwave reactor at maximal allowed 
power 500 W and 130 °C, using infrared flask-surface control of temperature, for 15 min. The solvent 
was evaporated under reduced pressure, the solid residue washed with 2 M HCl, and the crude product 
was recrystallized from propan-2-ol with addition of active carbon. 
N-Phenylnaphthalene-1-carboxamide (1). Method B; Yield 46%; Mp. 164 °C (164–165°C [55],  
163 °C [56], 160 °C [57]); Rf = 0.87; IR (Zn/Se ATR, cm−1): 3281m, 3045w, 1650s, 1594s, 1520s, 1499s, 
1433s, 1312m, 1253m, 1078s, 781s, 770s, 744s, 686m; 1H-NMR (DMSO-d6) [55,58,59], δ: 10.58 (s, 1H),  
8.22–8.17 (m, 1H), 8.08 (d, J = 8.1 Hz, 1H), 8.06–8.00 (m, 1H), 7.83 (d, J = 8.1 Hz, 2H), 7.76 (d,  
J = 5.9 Hz, 1H), 7.65–7.58 (m, 3H), 7.38 (t, J = 8.1 Hz, 2H), 7.13 (td, J = 7.3 Hz, J = 0.7 Hz, 1H);  
13C-NMR (DMSO-d6), δ: 167.14, 139.17, 134.73, 133.04, 129.86, 129.57, 128.51, 128.13, 126.76, 
126.14, 125.21, 124.96, 124.83, 123.51, 119.80; HR-MS: for C17H14NO [M+H]+ calculated  
248.1070 m/z, found 248.1079 m/z. 
N-(2-Methoxyphenyl)naphthalene-1-carboxamide (2a). Method A; Yield 89%; Mp. 117 °C; Rf = 0.72;  
IR (Zn/Se ATR, cm−1): 3321m, 3042w, 1651s, 1591m, 1505m, 1486s, 1456s, 1429m, 1259m, 1250m, 
1220m, 1112m, 1043m, 1026s, 901m, 813m, 802m, 785s, 760s, 738m, 723m; 1H-NMR (DMSO-d6), δ: 
9.60 (s, 1H), 8.32–8.27 (m, 1H), 8.07 (d, J = 8.4 Hz, 1H), 8.04–7.99 (m, 1H), 7.92 (d, J = 7.3 Hz, 1H), 
7.77 (d, J = 6.6 Hz, 1H), 7.63–7.56 (m, 3H), 7.26–7.09 (m, 2H), 7.01 (td, J = 7.5 Hz, J = 1.5 Hz, 1H), 
3.83 (s, 3H); 13C-NMR (DMSO-d6), δ: 167.12, 151.25, 134.51, 133.10, 129.99, 129.70, 128.14, 
126.96, 126.73, 126.15, 125.59, 125.27, 125.15, 124.89, 123.83, 120.16, 111.50, 55.69; HR-MS: for 
C18H16NO2 [M+H]+ calculated 278.1176 m/z, found 278.1181 m/z. 
N-(3-Methoxyphenyl)naphthalene-1-carboxamide (2b). Method A; Yield 93%; Mp. 161 °C; Rf = 0.69;  
IR (Zn/Se ATR, cm−1): 3280m, 3046w, 2966w, 1648s, 1592s, 1538s, 1493m, 1327m, 1307s, 1251s, 
1027m, 845s, 815m, 776s, 736m, 726m, 688s; 1H-NMR (DMSO-d6), δ: 10.57 (s, 1H), 8.20–8.15 (m, 
1H), 8.08 (d, J = 8.0 Hz, 1H), 8.05–8.00 (m, 1H), 7.74 (dd, J = 7.0 Hz, J = 1.5 Hz, 1H); 7.65–7.57 (m, 
3H), 7.53 (t, J = 1.5 Hz, 1H), 7.40–7.31 (m, 1H), 7.27 (t, J = 8.1 Hz, 1H), 6.71 (ddd, J = 8.1 Hz,  
J = 2.6 Hz, J = 1.1 Hz, 1H); 3.76 (s, 3H); 13C-NMR (DMSO-d6), δ: 167.23, 159.47, 140.39, 134.71, 
133.07, 129.96, 129.57, 129.37, 128.20, 126.85, 126.23, 125.27, 124.99, 124.89, 112.09, 109.11, 
105.67, 54.96; HR-MS: for C18H16NO2 [M+H]+ calculated 278.1176 m/z, found 278.1181 m/z. 
N-(4-Methoxyphenyl)naphthalene-1-carboxamide (2c). Method A; Yield 91%; Mp. 177 °C; Rf = 0.66;  
IR (Zn/Se ATR, cm−1): 3227m, 3125w, 3050w, 1647s, 1603s, 1506s, 1469m, 1414m, 1327m, 1227m, 
1180m, 1030m, 1026m, 834m, 821m, 799s, 777s, 747s, 730m; 1H-NMR (DMSO-d6) [58], δ: 10.45 (s, 
1H), 8.22–8.17 (m, 1H), 8.07 (d, J = 8.7 Hz, 1H), 8.05–8.00 (0, 1H), 7.75 (d, J = 7.7 Hz, 1H), 7.73 (d, 
J = 8.8 Hz, 2H), 7.64–7.57 (m, 3H), 6.96 (d, J = 9.1 Hz, 2H), 3.76 (s, 3H); 13C-NMR (DMSO-d6), δ: 
166.74, 155.51, 134.88, 133.07, 132.37, 129.78, 129.63, 128.16, 126.75, 126.17, 125.17, 125.07, 
124.89, 121.33, 113.77, 55.14; HR-MS: for C18H16NO2 [M+H]+ calculated 278.1176 m/z, found 
278.1177 m/z. 
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N-(2-Methylphenyl)naphthalene-1-carboxamide (3a). Method B; Yield 76%; Mp. 187 °C; Rf = 0.70;  
IR (Zn/Se ATR, cm−1): 3267m, 3046w, 1642s, 1572s, 1524s, 1456s, 1303m, 1258m, 718s, 771s, 747s, 
736s; 1H-NMR (DMSO-d6), δ: 10.06 (s, 1H), 8.32–8.28 (m, 1H), 8.08 (d, J = 8.4 Hz, 1H), 8.06–8.01 
(m, 1H), 7.83 (d, J = 6.6 Hz, 1H), 7.66–7.50 (m, 4H), 7.32–7.15 (m, 3H), 2.34 (s, 3H); 13C-NMR  
(DMSO-d6), δ: 167.35, 136.23, 134.64, 133.15, 133.4, 130.31, 129.93, 129.81, 128.22, 126.81, 126.24, 
126.23, 125.96, 125.87, 125.38, 125.18, 124.96, 17.96; HR-MS: for C18H16NO [M+H]+ calculated 
262.1226 m/z, found 262.1231 m/z. 
N-(3-Methylphenyl)naphthalene-1-carboxamide (3b). Method A; Yield 88%; Mp. 162 °C; Rf = 0.69;  
IR (Zn/Se ATR, cm−1): 3227m, 3133w, 3053w, 1651s, 1593s, 1538s, 1428m, 1305m, 1266m, 1252m, 
1206w, 805m, 776s, 745s, 734s, 691s; 1H-NMR (DMSO-d6), δ: 10.52 (s, 1H), 8.21–8.17 (m, 1H), 8.08 
(d, J = 8.1 Hz, 1H), 8.06–8.01 (m, 1H), 7.75 (d, J = 6.6 Hz, 1H), 7.70 (s, 1H), 7.76–7.58 (m, 4H), 7.26 (t, 
J = 7.6 Hz, 1H), 6.95 (d, J = 7.2 Hz, 1H), 2.33 (s, 3H); 13C-NMR (DMSO-d6), δ: 167.15, 139.13, 137.76, 
134.82, 133.07, 129.87, 129.60, 128.40, 128.17, 126.81, 126.18, 125.21, 125.02, 124.89, 124.27, 
120.34, 117.03, 21.10; HR-MS: for C18H16NO [M+H]+ calculated 262.1226 m/z, found 262.1230 m/z. 
N-(4-Methylphenyl)naphthalene-1-carboxamide (3c). Method A; Yield 95%; Mp. 196 °C (183 °C [56], 
190–193 °C [60], 187–189 °C [61]; Rf = 0.69; IR (Zn/Se ATR, cm−1): 3227m, 3180w, 3111w, 3031w, 
2909w, 1651s, 1598s, 1532s, 1514s, 1404m, 1322s, 1301m, 1257m, 817m, 805s, 778s, 747s, 730m;  
1H-NMR (DMSO-d6) [58,59], δ: 10.51 (s, 1H), 8.21–8.16 (m, 1H), 8.07 (d, J = 8.4 Hz, 1H), 8.05–8.00 
(m, 1H), 7.74 (dd, J = 7.0 Hz, J = 1.1 Hz, 1H), 7.71 (d, J = 8.1 Hz, 2H), 7.64–7.55 (m, 3H), 7.18 (d,  
J = 8.4 Hz, 2H), 2.30 (s, 3H); 13C-NMR (DMSO-d6), δ: 166.97, 136.70, 134.83, 133.06, 132.53, 
129.83, 129.61, 128.93, 128.16, 126.78, 126.17, 125.20, 125.03, 124.88, 119.81, 20.35; HR-MS: for 
C18H16NO [M+H]+ calculated 262.1226 m/z, found 262.1232 m/z. 
N-(2-Fluorophenyl)naphthalene-1-carboxamide (4a). Method A; Yield 94%; Mp. 141 °C (Mp.  
137–138 °C [62]); Rf = 0.69; IR (Zn/Se ATR, cm−1): 3172m, 3118w, 3013w, 1656s, 1530s, 1498s, 
1450s, 1313s, 1291s, 1261s, 1106m, 804m, 781s, 754s; 1H-NMR (DMSO-d6), δ: 10.38 (s, 1H),  
8.29–8.24 (m, 1H), 8.09 (d, J = 8.4 Hz, 1H), 8.05–8.00 (m, 1H), 7.80 (d, J = 6.6 Hz, 1H), 7.79–7.74 
(m, 1H), 7.65–7.55 (m, 3H), 7.39–7.23 (m, 3H); 13C-NMR (DMSO-d6), δ: 167.39, 155.33 (d,  
J = 245.8 Hz), 133.94, 133.07, 130.16, 129.70, 128.19, 126.84, 126.64 (d, J = 7.6 Hz), 126.45 (d,  
J = 2.3 Hz), 126.20, 125.64 (d, J = 12.2 Hz), 125.52, 125.03, 124.85, 124.21 (d, J = 3.1 Hz), 115.68 (d,  
J = 19.7 Hz); HR-MS: for C17H13NOF [M+H]+ calculated 266.0976 m/z, found 266.0982 m/z. 
N-(3-Fluorophenyl)naphthalene-1-carboxamide (4b). Method A; Yield 96%; Mp. 150 °C; Rf = 0.68;  
IR (Zn/Se ATR, cm−1): 3277m, 3039w, 1651s, 1611s, 1592s, 1522s, 1484m, 1414m, 1391m, 1249m, 
1148m, 1129m, 855m, 770s, 676m; 1H-NMR (DMSO-d6), δ: 10.80 (s, 1H), 8.21–8.16 (m, 1H), 8.10 (d,  
J = 8.1 Hz, 1H), 8.06–8.00 (m, 1H), 7.85–87.76 (m, 2H), 7.66–7.54 (m, 4H), 7.47–7.36 (m, 1H), 6.96 
(tdd, J = 8.4 Hz, J = 2.6 Hz, J = 1.1 Hz, 1H); 13C-NMR (DMSO-d6), δ: 167.42, 162.05 (d,  
J = 239.7 Hz), 140.90 (d, J = 10.7 Hz), 134.29, 133.06, 130.22 (d, J = 9.1 Hz), 130.19, 129.51, 128.22, 
126.96, 126.29, 125.44, 124.91, 124.88, 115.49 (d, J = 2.4 Hz), 110.03 (d, J = 21.3 Hz), 106.50 (d,  
J = 25.8 Hz); HR-MS: for C17H13NOF [M+H]+ calculated 266.0976 m/z, found 266.0981 m/z. 
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N-(4-Fluorophenyl)naphthalene-1-carboxamide (4c). Method A; Yield 78%; Mp. 185 °C; Rf = 0.69;  
IR (Zn/Se ATR, cm−1): 3284m, 3046w, 1648s, 1521s, 1505s, 1404s, 1390s, 1308m, 1206m, 1097m, 
826s, 807s, 778s, 760m, 701m; 1H-NMR (DMSO-d6) [58,59], δ: 10.66 (s, 1H), 8.22–8.17 (m, 1H), 
8.09 (d, J = 8.1 Hz, 1H), 8.06–8.01 (m, 1H), 7.86–7.81 (m, 2H), 7.77 (dd, J = 7.0 Hz, J = 1.5 Hz, 1H), 
7.65–7.56 (m, 3H), 7.23 (t, J = 9.0 Hz, 2H); 13C-NMR (DMSO-d6), δ: 167.08, 158.21 (d,  
J = 238.2 Hz), 135.58 (d, J = 2.3 Hz), 134.54, 133.07, 130.01, 129.57, 128.20, 126.87, 126.23, 125.32, 
125.00, 124.89, 121.57 (d, J = 7.6 Hz), 115.15 (d, J = 22.0 Hz); HR-MS: for C17H13NOF [M+H]+ 
calculated 266.0976 m/z, found 266.0981 m/z. 
N-(2-Chlorophenyl)naphthalene-1-carboxamide (5a). Method A; Yield 83%; Mp. 157 °C (Mp.  
154–156 °C [63]); Rf = 0.72; IR (Zn/Se ATR, cm−1): 3263m, 3046w, 1648s, 1581s, 1520s, 1505s, 
1475m, 1439m, 1301s, 1253m, 1059m, 815m, 786s, 777s, 743s; 1H-NMR (DMSO-d6), δ: 10.30 (s, 
1H), 8.37–8.32 (m, 1H), 8.10 (d, J = 8.4 Hz, 1H), 8.06–8.01 (m, 1H), 7.85 (d, J = 8.4 Hz, 1H),  
7.76–7.57 (m, 5H), 7.43 (td, J = 7.7 Hz, J = 1.5 Hz, 1H), 7.33 (td, J = 7.7 Hz, J = 1.8 Hz, 1H);  
13C-NMR (DMSO-d6), δ: 167.38, 134.85, 133.91, 133.10, 130.24, 129.73, 129.49, 129.16, 128.17, 
128.14, 127.39, 127.38, 126.84, 126.23, 125.59, 125.15, 124.86; HR-MS: for C17H13NOCl [M+H]+ 
calculated 282.0680 m/z, found 282.0685 m/z. 
N-(3-Chlorophenyl)naphthalene-1-carboxamide (5b). Method A; Yield 87%; Mp. 144 °C; Rf = 0.71;  
IR (Zn/Se ATR, cm−1): 3270m, 3050w, 1647s, 1585s, 1524s, 1478s, 1304s, 1249s, 863m, 775s, 744m, 
682s; 1H-NMR (DMSO-d6), δ: 10.78 (s, 1H), 8.21–8.16 (m, 1H), 8.11 (d, J = 8.1 Hz, 1H), 8.06–8.01 (m, 
2H), 7.78 (dd, J = 7.2 Hz, J = 1.1 Hz, 1H), 7.70 (d, J = 9.2 Hz, 1H), 7.63–7.56 (m, 3H), 7.41 (t, J = 8.0 Hz, 
1H), 7.20 (ddd, J = 7.7 Hz, J = 1.8 Hz, J = 0.7 Hz, 1H); 13C-NMR (DMSO-d6), δ: 167.44, 140.63, 
134.23, 133.07, 132.98, 130.30, 130.22, 129.51, 128.23, 126.97, 126.29, 125.46, 124.92, 124.88, 123.29, 
119.25, 118.16; HR-MS: for C17H13NOCl [M+H]+ calculated 282.0680 m/z, found 282.0685 m/z. 
N-(4-Chlorophenyl)naphthalene-1-carboxamide (5c). Method A; Yield 90%; Mp. 182 °C; Rf = 0.72;  
IR (Zn/Se ATR, cm−1): 3270m, 3042w, 1647s, 1590s, 1514s, 1489s, 1389m, 1310m, 1092m, 1014m, 
820s, 809m, 783s, 774s, 709m; 1H-NMR (DMSO-d6) [58,59], δ: 10.73 (s, 1H), 8.20–8.15 (m, 1H), 
8.09 (d, J = 8.1 Hz, 1H), 8.06–8.01 (m, 1H), 7.86 (d, J = 8.8 Hz, 2H), 7.77 (dd, J = 8.1 Hz, J = 1.1 Hz, 
1H), 7.65–7.56 (m, 3H), 7.44 (d, J = 8.8 Hz, 2H); 13C-NMR (DMSO-d6), δ: 167.24, 138.14, 134.38, 
133.06, 130.11, 129.52, 128.49, 128.22, 127.22, 126.91, 126.26, 125.40, 124.94, 124.88, 121.31;  
HR-MS: for C17H13NOCl [M+H]+ calculated 282.0680 m/z, found 282.0685 m/z. 
N-(2-Bromophenyl)naphthalene-1-carboxamide (6a) Method A; Yield 79%; Mp. 155 °C (Mp.  
147–150 °C [62], 149 °C [64]); Rf = 0.73; IR (Zn/Se ATR, cm−1): 3256m, 3042w, 1647s, 1575m, 
1520s, 1471m, 1432m, 1299m, 1253m, 1026m, 784s, 774s, 742s, 734s; 1H-NMR (DMSO-d6), δ: 10.27 
(s, 1H), 8.41–8.36 (m, 1H), 8.10 (d, J = 8.4 Hz, 1H), 8.06–8.01 (m, 1H), 7.88 (d, J = 7.0 Hz, 1H),  
7.83–7.60 (m, 5H), 7.48 (td, J = 7.7 Hz, J = 1.5 Hz, 1H), 7.26 (td, J = 7.7 Hz, J = 1.8 Hz, 1H);  
13C-NMR (DMSO-d6), δ: 167.29, 136.27, 133.88, 133.10, 132.62, 130.24, 129.73, 128.64, 128.14, 
128.01, 127.85, 126.79, 126.21, 125.55, 125.23, 124.82, 120.21; HR-MS: for C17H13NOBr [M+H]+ 
calculated 326.0175 m/z, found 326.0183 m/z. 
Molecules 2014, 19 10400 
 
 
N-(3-Bromophenyl)naphthalene-1-carboxamide (6b). Method A; Yield 90%; Mp. 152 °C; Rf = 0.71;  
IR (Zn/Se ATR, cm−1): 3266m, 3042w, 1647s, 1575m, 1520s, 1471s, 1432s, 1299s, 1253m, 1026m, 
784s, 774s, 742s, 734s; 1H-NMR (DMSO-d6) [59], δ: 10.77 (s, 1H), 8.21–8.16 (m, 2H), 8.11 (d,  
J = 8.1 Hz, 1H), 8.05–8.01 (m, 1H), 7.78 (dd, J = 7.0 Hz, J = 1.1 Hz, 1H), 7.74–7.71 (m, 1H),  
7.66–7.56 (m, 3H), 7.40–7.33 (m, 2H); 13C-NMR (DMSO-d6), δ: 167.41, 140.77, 134.20, 133.06, 
130.58, 130.22, 129.51, 128.22, 126.97, 126.29, 126.18, 125.46, 124.91, 124.86, 122.10, 121.42, 
118.54; HR-MS: for C17H13NOBr [M+H]+ calculated 326.0175 m/z, found 326.0183 m/z. 
N-(4-Bromophenyl)naphthalene-1-carboxamide (6c). Method A; Yield 84%; Mp. 195 °C; Rf = 0.72;  
IR (Zn/Se ATR, cm−1): 3216m, 3162w, 3100w, 3028w, 1648s, 1532m, 1486s, 1390m, 1318m, 1255m, 
1070m, 1010m, 814s, 788s, 774s, 742m, 726m; 1H-NMR (DMSO-d6) [59], δ: 10.73 (s, 1H), 8.22–8.14 
(m, 1H), 8.10 (d, J = 8.1 Hz, 1H), 8.06–7.99 (m, 1H), 7.81 (d, J = 8.8 Hz, 2H), 7.77 (d, J = 7.0 Hz, 
1H), 7.66–7.56 (m, 3H) 7.57 (d, J = 8.8 Hz, 2H); 13C-NMR (DMSO-d6), δ: 168.26, 138.55, 134.35, 
133.06, 131.40, 130.13, 129.51, 128.20, 126.91, 126.24, 125.40, 124.92, 124.86, 121.69, 115.23;  
HR-MS: for C17H13NOBr [M+H]+ calculated 326.0175 m/z, found 326.0184 m/z. 
N-[2-(Trifluoromethyl)phenyl]naphthalene-1-carboxamide (7a). Method B; Yield 74%; Mp. 151 °C;  
Rf = 0.87; IR (Zn/Se ATR, cm−1): 3249s, 3050w, 2999w, 1651s, 1585m, 1520s, 1452s, 1418s, 1297s, 
1256s, 1170s, 1110s, 1058s, 1036s, 910m, 797m, 778s, 764s, 726m; 1H-NMR (DMSO-d6), δ: 10.38 (s, 
1H), 8.33–8.28 (m, 1H), 8.10 (d, J = 8.1 Hz, 1H), 8.05–8.01 (m, 1H), 7.82–7.76 (m, 3H), 7.72–7.58 (m, 
5H); 13C-NMR (DMSO-d6), δ: 168.29, 135.46 (q, J = 3.9 Hz), 133.80, 133.15, 133.14, 131.16, 130.27, 
129.73, 128.22, 127.43, 126.85, 126.45 (q, J = 4.6 Hz), 126.29, 126.16 (q, J = 29.6 Hz), 125.44, 
125.14, 124.89, 123.70 (q, J = 276.2 Hz); HR-MS: for C18H13NOF3 [M+H]+ calculated 316.0944 m/z, 
found 316.0953 m/z. 
N-[3-(Trifluoromethyl)phenyl]naphthalene-1-carboxamide (7b). Method B; Yield 78%; Mp. 148 °C;  
Rf = 0.87; IR (Zn/Se ATR, cm−1): 3267m, 3046w, 1647s, 1529s, 1489s, 1330s, 1306s, 1254m, 1230m, 
1162s, 1131s, 1115s, 1094s, 1065s, 1012w, 929m, 880s, 793s, 780s, 744s, 698m; 1H-NMR (DMSO-d6), 
δ: 10.29 (s, 1H), 8.35 (s, 1H), 8.24–8.19 (m, 1H), 8.11 (d, J = 8.4 Hz, 1H), 8.10–8.01 (m, 2H), 7.81 (d,  
J = 6.6 Hz, 1H), 7.67–7.59 (m, 4H), 7.49 (d, J = 7.7 Hz, 1H); 13C-NMR (DMSO-d6), δ: 167.65, 139.99, 
134.09, 133.10, 130.39, 129.90, 129.54, 129.45 (q, J = 31.9 Hz), 128.29, 127.06, 126.37, 125.62, 
124.97, 124.91, 124.10 (q, J = 270.9 Hz), 123.30, 119.94 (q, J = 3.9 Hz), 115.83 (q, J = 3.3 Hz);  
HR-MS: for C18H13NOF3 [M+H]+ calculated 316.0944 m/z, found 316.0953 m/z. 
N-[4-(Trifluoromethyl)phenyl]naphthalene-1-carboxamide (7c). Method B; Yield 68%; Mp. 193 °C;  
Rf = 0.88; IR (Zn/Se ATR, cm−1): 3299m, 1657s, 1613m, 1597m, 1522s, 1511s, 1407m, 1328s, 1315s, 
1253m, 1155s, 1109s, 1067s, 1018s, 904m, 834s, 789m, 777s, 756m; 1H-NMR (DMSO-d6), δ: 10.95 
(s, 1H), 8.21–8.16 (m, 1H), 8.15 (d, J = 8.4 Hz, 1H), 8.09–8.02 (m, 3H), 7.83–7.74 (m, 3H), 7.67–7.59 
(m, 3H); 13C-NMR (DMSO-d6), δ: 167.70, 142.80, 134.12, 133.10, 130.39, 129.52, 128.31, 127.08, 
126.37, 125.96 (q, J = 3.8 Hz), 125.64, 124.93, 124.92, 124.36 (q, J = 269.6 Hz), 123.67 (q,  
J = 31.9 Hz), 119.68; HR-MS: for C18H13NOF3 [M+H]+ calculated 316.0944 m/z, found 316.0952 m/z. 
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N-(2-Nitrophenyl)naphthalene-1-carboxamide (8a). Method B; Yield 43%; Mp. 98 °C (Mp.  
138–139 °C [59]); Rf = 0.87; IR (Zn/Se ATR, cm−1): 3333m, 1677s, 1608m, 1584s, 1495s, 1418s, 
1336s, 1272s, 897m, 779s, 727s; 1H-NMR (DMSO-d6), δ: 11.00 (s, 1H), 8.33–8.28 (m, 1H), 8.14 (d,  
J = 8.1 Hz, 1H), 8.07–8.02 (m, 2H), 7.85 (dd, J = 7.0 Hz, J = 1.1 Hz, 1H), 7.79–7.60 (m, 5H), 7.46 (td, 
J = 7.5 Hz, J = 2.2 Hz, 1H); 13C-NMR (DMSO-d6), δ: 167.12, 143.21, 133.88, 133.16, 133.12, 131.01, 
130.89, 129.70, 128.31, 127.09, 126.43, 125.97, 125.93, 125.73, 124.99, 124.92, 124.85; HR-MS: for 
C17H13N2O3 [M+H]+ calculated 293.0921 m/z, found 293.0925 m/z. 
N-(3-Nitrophenyl)naphthalene-1-carboxamide (8b). Method A; Yield 79%; Mp. 172–175 °C; Rf = 0.87; 
IR (Zn/Se ATR, cm−1): 3278m, 3093w, 3045w, 1647s, 1526s, 1423m, 1340s, 1325s, 1290s, 1256s, 902m, 
881s, 834m, 806s, 777s, 735s; 1H-NMR (DMSO-d6) [59], δ: 11.08 (s, 1H), 8.89 (t, J = 2.2 Hz, 1H), 8.25–
8.20 (m, 1H), 8.16–8.11 (m, 2H), 8.07–7.97 (m, 2H), 7.84 (dd, J = 7.0 Hz, J = 1.1 Hz, 1H), 7.68 (t, J = 
8.1 Hz, 1H), 7.66–7.59 (m, 3H); 13C-NMR (DMSO-d6), δ: 167.74, 147.97, 140.34, 133.85, 133.12, 
130.54, 130.10, 129.52, 128.32, 127.13, 126.41, 125.75, 125.74, 124.93, 124.92, 118.14, 113.88; HR-
MS: for C17H13N2O3 [M+H]+ calculated 293.0921 m/z, found 293.0931 m/z. 
N-(4-Nitrophenyl)naphthalene-1-carboxamide (8c). Method B; Yield 60%; Mp. 213–215 °C; Rf = 0.87;  
IR (Zn/Se ATR, cm−1): 3195m, 3046w, 1655s, 1613m, 1593s, 1552s, 1504s, 1407s, 1327s, 1305s, 
1260s, 1107s, 856s, 845s, 821s, 766s, 749s, 686s; 1H-NMR (DMSO-d6) [59], δ: 11.20 (s, 1H), 8.31 (d, 
J = 9.2 Hz, 2H), 8.21–8.15 (m, 2H), 8.08 (d, J = 9.5 Hz, 2H), 8.05–8.02 (m, 1H), 7.84 (dd, J = 7.0 Hz, 
J = 1.1 Hz, 1H), 7.68–7.59 (m, 3H); 13C-NMR (DMSO-d6), δ: 167.85, 145.36, 142.51, 133.71, 133.09, 
130.65, 129.46, 128.34, 127.19, 126.41, 125.85, 124.89, 124.82, 124.81, 119.48; HR-MS: for 
C17H13N2O3 [M+H]+ calculated 293.0921 m/z, found 293.0926 m/z. 
3.3. Lipophilicity Determination Using HPLC (Capacity Factor k /Calculated log k) 
A HPLC system Agilent 1200 equipped with DAD detector (Agilent, USA) was used. A 
chromatographic column Symmetry® C18 5 μm, 4.6  250 mm, Part No. WAT054275 (Waters Corp., 
Milford, MA, USA) was used. The HPLC separation process was monitored and evaluated by 
EZChrom Elite software ver. 3.3.2 (Agilent, USA). Isocratic elution by a mixture of MeOH p.a. (60%) 
and H2O-HPLC Mili-Q grade (40%) as a mobile phase was used. The total flow of the column was  
1.0 mL/min, injection 20 μL, column temperature 40 °C, and sample temperature 10 °C. The detection 
wavelength 210 nm was chosen. The KI methanolic solution was used for the dead time (tD) 
determination. Retention times (tR) were measured in minutes. The capacity factors k were calculated 
according to formula k = (tR − tD)/tD, where tR is the retention time of the solute, whereas tD denotes the 
dead time obtained using an unretained analyte. Log k, calculated from the capacity factor k, is used as 
the lipophilicity index converted to log P scale. The log k values of individual compounds are shown 
in Table 1. 
3.4. In Vitro Antimycobacterial Evaluation 
A well-characterized clinical isolate of Mycobacterium avium subsp. paratuberculosis (CIT03) was 
grown in Middlebrook broth (MB), supplemented with Oleic-Albumin-Dextrose-Catalase supplement 
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(OADC, Becton, Dickinson and Comp., Franklin Lakes, NJ, USA) and mycobactin J (2 µg/mL). 
Identification of this isolate was performed using biochemical and molecular protocols. At log phase 
growth, a culture sample (10 mL) was centrifuged at 15,000 rpm/20 min using a bench top centrifuge 
(Model CR 4-12, Jouan Inc., Winchester, VA, USA). Following removal of the supernatant, the pellet 
was washed in fresh Middlebrook 7H9GC broth and re-suspended in fresh supplemented MB (10 mL). 
The turbidity was adjusted to match McFarland standard No. 1 (3 × 108 cfu) with MB broth. A further 
1:20 dilution of the culture was then performed in MB broth. The antimicrobial susceptibility of the 
mycobacterial species was investigated in a 96-well plate format. In these experiments, sterile 
deionized water (300 µL) was added to all outer-perimeter wells of the plates to minimize evaporation 
of the medium in the test wells during incubation. Each evaluated compound (100 µL) was incubated 
with the mycobacterial species (100 µL). Dilutions of each compound were prepared in duplicate. For 
all synthesized compounds, final concentrations ranged from 1,000 µg/mL to 8 µg/mL. All compounds 
were prepared in DMSO and subsequent dilutions were made in supplemented MB. The plates were 
sealed with parafilm and incubated at 37 °C for 11 days. 
Following incubation, a 10% addition of alamarBlue (AbD Serotec, Kidlington, UK) was mixed 
into each well and readings at 570 nm and 600 nm were taken, initially for background subtraction and 
subsequently after 24 h re-incubation. The background subtraction is necessary for strongly coloured 
compounds, where the colour may interfere with the interpretation of any colour change. For  
non-interfering compounds, a blue colour in the well was interpreted as an absence of growth and a 
pink colour was scored as growth. Furthermore percent reduction of alamarBlue was calculated to 
generate quantitative data on cell viability during exposure to antimycobacterial compounds over a 
period of 5 days. The formula used to determine percent reduction of alamarBlue has been 
standardized for colorimetric analysis by Abd Serotec. 
For the MTT assay, the same 96-well plate set up and incubation conditions listed above were used. 
After the incubation period, a 10% addition of MTT reagent was mixed into each well and incubated at 
37 °C for 4 h. The reagent and media were then aspirated from the wells to which 50 µL DMSO was 
then added and plates were read at 550 nm. 
The actimycobacterial activity was expressed as the minimum inhibitory concentration (MIC) that 
is defined for mycobacteria as a 90% or greater (IC90) reduction of growth in comparison with the 
control. The MIC value is routinely and widely used in bacterial assays and is a standard detection 
limit according to the Clinical and Laboratory Standards Institute [47]. Isoniazid, rifampicin and 
ciprofloxacin (Sigma-Aldrich) were used as reference antimycobacterial drugs. The results are 
summarized in Table 1. 
3.5. In Vitro Cytotoxicity Assay 
Human monocytic leukemia THP-1 cells were obtained from the European Collection of Cell 
Cultures (ECACC, Salisbury, UK; Methods of characterization: DNA Fingerprinting (Multilocus 
probes) and isoenzyme analysis). These cells were routinely cultured in RPMI 1640 (Lonza, Verviers, 
Belgium) medium supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich, St. Louis, MO, 
USA), 2% L-glutamine, 1% penicillin and streptomycin (Lonza) at 37 °C with 5% CO2. Cells were 
passaged at approximately one-week intervals. Cells were routinely tested for the absence of 
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mycoplasma (Hoechst 33258 staining method). The tested compounds were dissolved in DMSO 
(Sigma-Aldrich) and added in five increasing concentrations to the cell suspension in the culture 
medium. The maximum concentration of DMSO in the assays never exceeded 0.1%. Subsequently, the 
cells were incubated for 24 h at 37 °C with 5% CO2 to various compound concentrations ranging from 
0.37 to 20 μmol/L in RPMI 1640 medium. Cell toxicity was determined using a Cytotoxicity Detection 
KitPLUS Lactate dehydrogenase (LDH) assay kit (Roche Diagnostics, Mannheim, Germany) according 
to the manufacturer’s instructions, as described previously [10–13]. For LDH assays, cells were seeded 
into 96-well plates (5 × 104 cells/well in 100 μL culture medium) in triplicate in serum-free RPMI 
1640 medium, and measurements at 492 nm wavelength (Synergy 2 Multi-Mode Microplate Reader, 
BioTek, Winooski, VT, USA) were taken 24 h after the treatment with tested compounds. The median 
lethal dose values, LD50, were deduced through the production of a dose-response curve. All data were 
evaluated using GraphPad Prism 5.00 software (GraphPad Software, San Diego, CA, USA). The 
results are summarized in Table 1. 
LDH Test Principle: The LDH activity is determined by a coupled enzymatic reaction, whereby the 
tetrazolium salt INT is reduced to formazan. An increase in the amount of dead or plasma membrane 
damaged cells results in an increase of LDH enzyme activity in the culture supernatant. This increase 
in the amount of enzyme activity in the supernatant directly correlates to the amount of formazan 
formed during a limited time period. The formazan dye formed is water soluble and shows a broad 
absorption maximum at approximately 500 nm. 
3.6. Study of Inhibition Photosynthetic Electron Transport (PET) in Spinach Chloroplasts 
Chloroplasts were prepared from spinach (Spinacia oleracea L.) according to Masarovicova and 
Kralova [65]. The inhibition of photosynthetic electron transport (PET) in isolated spinach 
chloroplasts was determined spectrophotometrically (Genesys 6, Thermo Scientific, USA), using an 
artificial electron acceptor 2,6-dichlorophenol-indophenol (DCIPP) according to Kralova et al. [66], 
and the rate of photosynthetic electron transport was monitored as a photoreduction of DCPIP. The 
measurements were carried out in phosphate buffer (0.02 mol/L, pH 7.2) containing sucrose (0.4 mol/L), 
MgCl2 (0.005 mol/L) and NaCl (0.015 mol/L). The chlorophyll content was 30 mg/L in these 
experiments and the samples were irradiated (~100 W/m2 with 10 cm distance) with a halogen lamp 
(250 W) using a 4 cm water filter to prevent warming of the samples (suspension temperature 22 °C). 
The studied compounds were dissolved in DMSO due to their limited water solubility. The applied 
DMSO concentration (up to 4%) practically did not affect the photochemical activity in isolated 
spinach chloroplasts (observed differences in DCPIP photoreduction due DMSO addition were within 
experimental error). The inhibitory efficiency of the studied compounds was expressed by IC50 values, 
i.e., by molar concentration of the compounds causing 50% decrease in the oxygen evolution rate 
relative to the untreated control. The comparable IC50 value for a selective herbicide 3-(3,4-
dichlorophenyl)-1,1-dimethylurea, DCMU (Diuron®) was about 1.9 μmol/L. The results are 
summarized in Table 1. 
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4. Conclusions 
A series of twenty-two substituted naphthalene-1-carboxanilides were prepared and characterized. 
The prepared compounds were tested for their antimycobacterial activity against clinical isolate of 
Mycobacterium avium subsp. paratuberculosis and for their ability to inhibit photosynthetic electron 
transport (PET) in isolated spinach chloroplasts (Spinacia oleracea L.). Generally compounds showed 
poor aqueous solubility, which significantly reduced their biological effect. Five compounds,  
N-(2-methoxyphenyl)naphthalene-1-carboxamide (2a), N-(3-methoxyphenyl)naphthalene-1-carboxamide 
(2b), N-(3-methylphenyl)naphthalene-1-carboxamide (3b), N-(4-methylphenyl)-naphthalene-1-
carboxamide (3c) and N-(3-fluorophenyl)naphthalene-1-carboxamide (4b) showed antimycobacterial 
activity two-fold higher than rifampicin and three-fold higher activity than ciprofloxacin. It was found 
that dependence of the antimycobacterial activities on lipophilicity and electronic properties were 
bilinear. Based on the results of the MTT assay of the most efficient compounds 2a, 2b, 3c, and 4b it 
seems that they could influence the mycobacterial respiratory chain. The most effective antimycobacterial 
compounds 2a, 2b, 3b, 3c and 4b were tested for their in vitro cytotoxicity against THP-1 cells  
and within this preliminary screening they demonstrated insignificant toxicity. Based on these facts, it 
can be concluded that the discussed anilides can be considered as promising agents for subsequent 
design of novel antimycobacterial agents. The PET-inhibiting activity was rather moderate or low,  
the most active compound N-[4-(trifluoromethyl)-phenyl]naphthalene-1-carboxamide (7c) expressed 
IC50 = 59 μmol/L. 
Acknowledgements 
This study was supported by the IGA VFU Brno 37/2014/FaF, by the Slovak Grant Agency VEGA 
1/0612/11, by the Projects APVV-0061-11, CZ.1.07/2.3.00/30.0053, CZ.1.05/1.1.00/02.0073 and by 
the Irish Department of Agriculture Fisheries and Food (FIRM) 08RDCIT601 & 08RDCIT617. 
Author Contributions 
Tomas Gonec, Jiri Kos, Josef Jampilek—design, synthesis of the compounds, SAR, writing of the 
paper. Jan Tengler, Michal Oravec—analysis/characterization of the compounds. Eoghan Nevin,  
Rodney Govender, Jim O’Mahony, Aidan Coffey—antimycobacterial evaluation of the compounds, 
writing of the paper. Matus Pesko, Katarina Kralova—study of PET inhibition in spinach chloroplasts 
of the compounds, writing of the paper. Ivan Kushkevych, Vendula Stastna, Peter Kollar—evaluation 
of cytotoxicity of the compounds. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. World Health Organization. Global Tuberculosis Report 2013; WHO Press: Geneva, Switzerland, 
2013. 
Molecules 2014, 19 10405 
 
 
2. Wagner, D.; Young, L.S. Nontuberculous mycobacterial infections: A clinical review. Infection 
2004, 32, 257–270. 
3. Koul, A.; Arnoult, E.; Lounis, N.; Guillemont, J.; Andries, K. The challenge of new drug 
discovery for tuberculosis. Nature 2011, 469, 483–490. 
4. Shaner, D.L. Herbicide safety relative to common targets in plants and mammals. Pest. Manag. Sci. 
2004, 60, 17–24. 
5. Delaney, J.; Clarke, E.; Hughes, D.; Rice, M. Modern agrochemical research: A missed 
opportunity for drug discovery? Drug Discov. Today 2006, 11, 839–845. 
6. Duke, S.O. Herbicide and pharmaceutical relationships. Weed Sci. 2010, 58, 334–339. 
7. Dolezal, M.; Cmedlova, P.; Palek, L.; Vinsova, J.; Kunes, J.; Buchta, V.; Jampilek, J.; Kralova, K. 
Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides. Eur. J. Med. Chem. 
2008, 43, 1105–1113. 
8. Imramovsky, A.; Pesko, M.; Kralova, K.; Vejsova, M.; Stolarikova, J.; Vinsova, J.; Jampilek, J. 
Investigating spectrum of biological activity of 4- and 5-chloro-2-hydroxy-N-[2-(arylamino)-1-
alkyl-2-oxoethyl]benzamides. Molecules 2011, 16, 2414–2430. 
9. Gonec, T.; Bobal, P.; Sujan, J.; Pesko, M.; Guo, J.; Kralova, K.; Pavlacka, L.; Vesely, L.; 
Kreckova, E.; Kos, J.; et al. Investigating the spectrum of biological activity of substituted 
quinoline-2-caboxamides and their isosteres. Molecules 2012, 17, 613–644. 
10. Kos, J.; Zadrazilova, I.; Pesko, M.; Keltosova, S.; Tengler, J.; Gonec, T.; Bobal, P.; Kauerova, T.; 
Oravec, M.; Kollar, P.; et al. Antibacterial and herbicidal activity of ring-substituted  
3-hydroxynaphthalene-2-carboxanilides. Molecules 2013, 18, 7977–7997. 
11. Gonec, T.; Kos, J.; Zadrazilova, I.; Pesko, M.; Govender, R.; Keltosova, S.; Chambel, B.; Pereira, D.; 
Kollar, P.; Imramovsky, A.; et al. Antibacterial and herbicidal activity of ring-substituted  
2-hydroxynaphthalene-1-carboxanilides. Molecules 2013, 18, 9397–9419. 
12. Gonec, T.; Kos, J.; Zadrazilova, I.; Pesko, M.; Keltosova, S.; Tengler, J.; Bobal, P.; Kollar, P.; 
Cizek, A.; Kralova, K.; et al. Antimycobacterial and herbicidal activity of ring-substituted  
1-hydroxynaphthalene-2-carboxanilides. Bioorg. Med. Chem. 2013, 21, 6531–6541. 
13. Fajkusova, D.; Pesko, M.; Keltosova, S.; Guo, J.; Oktabec, Z.; Vejsova, M.; Kollar, P.; Coffey, A.; 
Csollei, J.; Kralova, K.; et al. Anti-infective and herbicidal activity of N-substituted 
2-aminobenzothiazoles. Bioorg. Med. Chem. 2012, 20, 7059–7068. 
14. Kralova, K.; Sersen, F.; Cizmarik, J. Inhibitory effect of piperidinoethylesters of 
alkoxyphenylcarbamic acids on photosynthesis. Gen. Physiol. Biophys. 1992, 11, 261–267. 
15. Kralova, K.; Bujdakova, H.; Kuchta, T.; Loos, D. Correlation between biological activity and the 
structure of 6-amino-2-R-thiobenzothiazoles. Anti-yeast activity and inhibition of photochemical 
activity of chloroplasts. Pharmazie 1994, 49, 460–461. 
16. Kralova, K.; Kallova, J.; Loos, D.; Devinsky, F. Correlation between biological activity and the 
structure of N,N'-bis(alkyldimethyl)-1,6-hexanediammonium dibromides. Antibacterial activity 
and inhibition of photochemical activity of chloroplasts. Pharmazie 1994, 49, 857–858. 
17. Bujdakova, H.; Kralova, K.; Sidoova, E. Antifungal and antialgal activity of 3-(2-alkylthio-6-
benzothiazolylaminomethyl)-2-benzoxazolinethiones. Pharmazie 1995, 50, 156–156. 
18. Kralova, K.; Bujdakova, H.; Cizmarik, J. Antifungal and antialgal activity of piperidinopropyl 
esters of alkoxy substituted phenylcarbamic acids. Pharmazie 1995, 50, 440–441. 
Molecules 2014, 19 10406 
 
 
19. Laursen, J.S.; Engel-Andreasen, J.; Fristrup, P.; Harris, P.; Olsen, C.A. Cis-trans amide bond 
rotamers in β-peptoids and peptoids: Evaluation of stereoelectronic effects in backbone and side 
chains. J. Am. Chem. Soc. 2013, 135, 2835–2844. 
20. Pattabiraman, V.R.; Bode, J.W. Rethinking amide bond synthesis. Nature 2011, 480, 471–479. 
21. Roth, H.J.; Fenner, H. Arzneistoffe, 3rd ed.; Deutscher Apotheker Verlag: Stuttgart, Germany, 
2000; pp. 51–114. 
22. Sinning, C.; Watzer, B.; de Petrocellis, L.; di Marzo, V.; Imming, P. Dopamides, vanillylamides, 
ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances 
as TRPV1 ligands. Chem. Med. Chem. 2008, 3, 1956–1964. 
23. Good, N.E. Inhibitors of the Hill reaction. Plant Physiol. 1961, 36, 788–803. 
24. Musiol, R.; Tabak, D.; Niedbala, H.; Podeszwa, B.; Jampilek, J.; Kralova, K.; Dohnal, J.; Finster, J.; 
Mencel, A.; Polanski, J. Investigating biological activity spectrum for novel quinoline analogues 
2: Hydroxyquinolinecarboxamides with photosynthesis inhibiting activity. Bioorg. Med. Chem. 
2008, 16, 4490–4499. 
25. Imramovsky, A.; Vinsova, J.; Monreal-Ferriz, J.; Dolezal, R.; Jampilek, J.; Kaustova, J.; Kunc, F. 
New antituberculotics originated from salicylanilides with promising in vitro activity against 
atypical mycobacterial strains. Bioorg. Med. Chem. 2009, 17, 3572–3579. 
26. Otevrel, J.; Mandelova, Z.; Pesko, M.; Guo, J.; Kralova, K.; Sersen, F.; Vejsova, M.; Kalinowski, D.; 
Kovacevic, Z.; Coffey, A.; et al. Investigating the spectrum of biological activity of ring-
substituted salicylanilides and carbamoylphenylcarbamates. Molecules 2010, 15, 8122–8142. 
27. Imramovsky, A.; Pesko, M.; Monreal-Ferriz, J.; Kralova, K.; Vinsova, J.; Jampilek, J. 
Photosynthesis-inhibiting efficiency of 4-chloro-2-(chlorophenylcarbamoyl)phenyl alkyl-carbamates. 
Bioorg. Med. Chem. Lett. 2011, 21, 4564–4567. 
28. Pauk, K.; Zadrazilova, I.; Imramovsky, A.; Vinsova, J.; Pokorna, M.; Masarikova, M.; Cizek, A.; 
Jampilek, J. New derivatives of salicylamides: Preparation and antimicrobial activity against 
various bacterial species. Bioorg. Med. Chem. 2013, 21, 6574–6581. 
29. Andries, K.; Verhasselt, P.; Guillemont, J.; Gohlmann, H.W.; Neefs, J.M.; Winkler, H.;  
van Gestel, J.; Timmerman, P.; Zhu, M.; Lee, E.; et al. A diarylquinoline drug active on the ATP 
synthase of Mycobacterium tuberculosis. Science 2005, 307, 223–227. 
30. Jampilek, J.; Dolezal, M.; Kunes, J.; Buchta, V.; Kralova, K. Quinaldine derivatives: Preparation 
and biological activity. Med. Chem. 2005, 1, 591–599. 
31. Musiol, R.; Jampilek, J.; Buchta, V.; Niedbala, H.; Podeszwa, B.; Palka, A.; Majerz-Maniecka, K.; 
Oleksyn, B.; Polanski, J. Antifungal properties of new series of quinoline derivatives. Bioorg. 
Med. Chem. 2006, 14, 3592–3598. 
32. Musiol, R.; Jampilek, J.; Kralova, K.; Richardson, D.R.; Kalinowski, D.; Podeszwa, B.; Finster, J.; 
Niedbala, H.; Palka, A.; Polanski, J. Investigating biological activity spectrum for novel quinoline 
analogues. Bioorg. Med. Chem. 2007, 15, 1280–1288. 
33. Podeszwa, B.; Niedbala, H.; Polanski, J.; Musiol, R.; Tabak, D.; Finster, J.; Serafin, K.; Wietrzyk, J.; 
Boryczka, S.; Mol, W.; et al. Investigating the antiproliferative activity of quinoline-5,8-dione 
analogues on tumour cell lines. Bioorg. Med. Chem. Lett. 2007, 17, 6138–6141. 
Molecules 2014, 19 10407 
 
 
34. Jampilek, J.; Musiol, R.; Finster, J.; Pesko, M.; Carroll, J.; Kralova, K.; Vejsova, M.; Coffey, A.; 
Polanski, J. Investigating biological activity spectrum for novel styrylquinazoline analogues. 
Molecules 2009, 14, 4246–4265. 
35. Mrozek-Wilczkiewicz, A.; Kalinowski, D.; Musiol, R.; Finster, J.; Kovacevic, Z.; Jampilek, J.; 
Rzeszowska-Wolny, J.; Richardson, D.R.; Polanski, J. Investigating anti-proliferative activity of 
styrylazanaphthalenes and azanaphthalenediones. Bioorg. Med. Chem. 2010, 18, 2664–2671. 
36. Serda, M.; Mrozek-Wilczkiewicz, A.; Jampilek, J.; Pesko, M.; Kralova, K.; Vejsova, M.; Musiol, R.; 
Polanski, J. Investigation of biological properties for (hetero)aromatic thiosemicarbazones. 
Molecules 2012, 17, 13483–13502. 
37. Cieslik, W.; Musiol, R.; Nycz, J.; Jampilek, J.; Vejsova, M.; Wolff, M.; Machura, B.; Polanski, J. 
Contribution to investigation of antimicrobial activity of styrylquinolines. Bioorg. Med. Chem. 
2012, 20, 6960–6968. 
38. Rokade, Y.B.; Sayyed, R.Z. Naphthalene derivatives: A new range of antimicrobials with high 
therapeutic value. Rasayan J. Chem. 2009, 2, 972–980. 
39. Durrant, J.D.; Hall, L.; Swift, R.V.; Landon, M.; Schnaufer, A.; Schnaufer, A.; Amaro, R.E. 
Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1. PLoS Negl. 
Trop. Dis. 2010, doi:10.1371/journal.pntd.0000803. 
40. Parineeta, B.N. Derivatives of 1-chloromethyl naphthalene: Synthesis and microbiological 
evaluation as potential antifungal agents. Der Pharma Chem. 2011, 3, 105–111. 
41. Kanno, T.; Tanaka, A.; Shimizu, T.; Nakano, T.; Nishizaki, T. 1-[2-(2-Methoxyphenylamino) 
ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol as a potential anticancer drug. Pharmacology 
2013, 91, 339–345. 
42. Damu, G.L.V.; Wang, Q.P.; Zhang, H.Z.; Zhang, Y.Y.; Lv, J.S.; Zhou, C.H. A series of 
naphthalimide azoles: Design, synthesis and bioactive evaluation as potential antimicrobial 
agents. Sci. Chin. Chem. 2013, 56, 952–969. 
43. Draber, W.; Tietjen, K.; Kluth, J.F.; Trebst, A. Herbicides in photosynthesis research.  
Angew. Chem. 1991, 3, 1621–1633. 
44. Tischer, W.; Strotmann, H. Relationship between inhibitor binding by chloroplasts and inhibition 
of photosynthetic electron-transport. Biochim. Biophys. Acta 1977, 460, 113–125. 
45. Trebst, A.; Draber, W. Structure activity correlations of recent herbicides in photosynthetic 
reactions. In Advances in Pesticide Science; Greissbuehler, H., Ed.; Pergamon Press: Oxford, UK, 
1979; pp. 223–234. 
46. Bowyer, J.R.; Camilleri, P.; Vermaas, W.F.J. Photosystem II and its interaction with herbicides. 
In Herbicides, Topics in Photosynthesis; Baker, N.R., Percival, M.P., Eds.; Elsevier: Amsterdam, 
The Netherlands, 1991; Volume 10, pp. 27–85. 
47. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, 
Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24-A2, 2nd ed; National 
Committee for Clinical Laboratory Standards: Wayne, PA, USA, 2011. 
48. Carroll, J.; Douarre, P.; Coffey, A.; Buckley, J.; Cashman, B.; O’Farrell, K.; O’Mahony, J. 
Optimization of a rapid viability assay for Mycobacterium avium paratuberculosis by using 
alamarBlue. Appl. Environ. Microbiol. 2009, 75, 7870–7872. 
Molecules 2014, 19 10408 
 
 
49. Bueno, J. Antitubercular in vitro drug discovery: Tools for begin the search. In Understanding 
Tuberculosis-New Approaches to Fighting against Drug Resistance; Cardona, P.J., Ed.; In Tech: 
Rijeka, Croatia, 2012; pp. 147–168. 
50. Janin, Y.L. Antituberculosis drugs: Ten years of research. Bioorg. Med. Chem. 2007, 15,  
2479–2513. 
51. Bueno, R.V.; Braga, R.C.; Segretti, N.D.; Ferreir, E.I.; Trossini, G.H.; Andrade, C.H.  
New tuberculostatic agents targeting nucleic acid biosynthesis: Drug design using QSAR 
approaches. Curr. Pharm. Des. 2014, 20, 4474–4485. 
52. Koul, A.; Vranckx, L.; Dhar, N.; Gohlmann, H.W.H.; Ozdemir, E.; Neefs, J.M.; Schulz, M.; Lu, P.; 
Mortz, E.; McKinney, J.D.; et al. Delayed bactericidal response of Mycobacterium tuberculosis to 
bedaquiline involves remodelling of bacterial metabolism. Nat. Commun. 2014, 
doi:10.1038/ncomms4369. 
53. Suffness, M.; Douros, J. Current status of the NCI plant and animal product program. J. Nat. Prod. 
1982, 45, 1–14. 
54. Bell, F. CCLVII.–The migration of acyl grups in o-aminophenols. J. Chem. Soc. 1930, 1981–1987. 
doi:10.1039/JR9300001981. 
55. Kumar, K.N.; Sreeramamurthy, K.; Palle, S.; Mukkanti, K.; Das, P. Dithiocarbamate and  
DBU-promoted amide bond formation under microwave condition. Tetrahedron Lett. 2010, 51, 
899–902. 
56. Kobs, U.; Neumann, W.P. Facile and effective synthesis of unusually substituted aromatic  
N-phenylamides. Chem. Ber. 1990, 123, 2191–2194. 
57. Shah, R.; Deshpande, R.K. A simplified method for the preparation of anilides. J. Uni. Bombay 
1933, 2, 125–127. 
58. Strukil, V.; Bartolec, B.; Portada, T.; Dilovic, I.; Halasz, I.; Margetic, D. One-pot mechanosynthesis 
of aromatic amides and dipeptides from carboxylic acids and amines. Chem. Commun. 2012, 48, 
12100–12102. 
59. Liu, L.H.; Guo, L.; Liu, C.H.; Zhang, X.; Jiang, Y.B. Intramolecular charge transfer with 1-
naphthanilides and 2-naphthanilides. Chin. J. Chem. 2005, 23, 857–864. 
60. Zhang, Z.; Yu, Y.; Liebeskind, L.S. N-Amidation by copper-mediated cross-coupling of 
organostannanes or boronic acids with O-acetyl hydroxamic acids. Org. Lett. 2008, 10,  
3005–3008. 
61. Bahrami, K.; Khodaei, M.M.; Targhan, H.; Arabi, M.S. Preparation of esters and amides from 
carboxylic acids and N-formylation of amines promoted by 1,3,5-triazo-2,4,6-triphosphorine-
2,2,4,4,6,6-hexachloride. Tetrahedron Lett. 2013, 54, 5064–5068. 
62. Tambade, P.J.; Patil, Y.P.; Bhanage, B.M. Palladium bis(2,2,6,6-tetramethyl-3,5-heptanedionate 
catalyzed alkoxycarbonylation and aminocarbonylation reactions. Appl. Organometal. Chem. 
2009, 23, 235–240. 
63. El-Sheikh, M.I.; Marks, A.; Biehl, E.R. Investigation of the synthesis of benzoxazole via aryne 
reaction. J. Org. Chem. 1981, 46, 3256–3259. 
64. Aluri, B.R.; Niaz, B.; Kindermann, M.K.; Jones, P.G.; Heinicke, J. P-C-N-Heterocycles: 
Synthesis of biaryl-type 1,3-benzazaphospholes with ortho-substituted phenyl or 2-heteroaryl 
groups. Dalton Trans. 2011, 40, 211–224. 
Molecules 2014, 19 10409 
 
 
65. Masarovicova, E.; Kralova, K. Approaches to measuring plant photosynthesis activity. In 
Handbook of Photosynthesis, 2nd ed.; Pessarakli, M., Ed.; Taylor & Francis Group: Boca Raton, 
FL, USA, 2005; pp. 617–656. 
66. Kralova, K.; Sersen, F.; Sidoova, E. Photosynthesis inhibition produced by 2-alkylthio-6-R-
benzothiazoles. Chem. Pap. 1992, 46, 348–350. 
Sample Availability: Samples of the compounds are available from the authors. 
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
